Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

Journal of Clinical Oncology

Volumn 19, Issue 8, 2001, Pages 2171-2178

  Ratner, L ^a   Lee, J ^a   Tang, S ^a   Redden, D ^a   Hamzeh, F ^a   Herndier, B ^a   Scadden, D ^a   Kaplan, L ^a   Ambinder, R ^a   Levine, A ^a   Harrington, W ^a   Grochow, L ^a   Flexner, C ^a   Tan, B ^a   Straus, D ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR RECEPTOR; INDINAVIR; LAMIVUDINE; PREDNISONE; STAVUDINE; VINCRISTINE;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CONSTIPATION; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG CLEARANCE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0035871554     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.8.2171     Document Type: Article

References (32)

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
2. The epidemiology of acquired immunodeficiency syndrome-related lymphomas
3. Spectrum of AIDS-associated malignant disorders
4. Kaposi's sarcoma and non-Hodgkin's lymphoma following the diagnosis of AIDS: Multistate AIDS/Cancer Match Study Group
5. AIDS-associated malignancies: Research perspectives
6. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: Prospective cohort study
7. The epidemiology of AIDS-associated non-Hodgkin's lymphoma in the World Health Organization European Region
8. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS): The New York University experience with 105 patients (1981-1986)
9. AIDS-associated non-Hodgkin's lymphoma in San Francisco
10. Human immunodeficiency virus-related lymphoma: Prognostic factors predictive of survival
11. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: Analysis of AIDS Clinical Trials Group protocol 142 - Low-dose versus standard-dose mBACOD plus granulocyte-macrophage colony-stimulating factor
12. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: A single institute study of 96 patients
13. AIDS-related lymphoid neoplasia: The Memorial Hospital experience
14. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy
15. Influence of molecular characteristics on clinical outcome in human immunodeficiency virus-associated non-Hodgkin's lymphoma: Identification of a subgroup with favorable clinical outcome
16. AIDS-related malignant lymphoma: Results of prospective treatment trials
17. Randomized trial of standard-dose vs low-dose mBACOD chemotherapy for HIV-associated non-Hodgkin's lymphoma
18. Antiretroviral therapy and immunomodulators in patients with AIDS
19. Acquired immunodeficiency syndrome-related lymphoma
20. Human immunodeficiency virus-related lymphoma: Prognostic factors predictive of survival
21. Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma: A prospective multi-institutional trial
22. Treatment of AIDS-related non-Hodgkin's lymphoma with chemotherapy (CNOP) and rhu-G-CSF: Clinical outcome and effect on HIV-1 viral load
23. Long-term follow-up of CEOP in the treatment of HIV related non-Hodgkin's lymphoma
24. Phase II trial of infusion cyclophosphamide, doxorubicin, and etoposide (CDE) in HIV-associated non-Hodgkin's lymphoma: An Eastern Cooperative Oncology Group Trial
25. Treatment of HIV-related non-Hodgkin's lymphoma adapted to prognostic factors
26. Dose adjusted EPOCH chemotherapy in previously untreated HIV-associated non-Hodgkin's lymphoma: Preliminary report of efficacy, immune reconstitution, and HIV control following therapy
27. HIV viral load markers in clinical practice
28. Change in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS
29. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion
30. HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy
31. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors
32. Replication of human immunodeficiency virus in monocytes